...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Survival rates, prognostic factors and treatment of anaplastic meningiomas
【24h】

Survival rates, prognostic factors and treatment of anaplastic meningiomas

机译:间变性脑膜瘤的生存率,预后因素和治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Intracranial anaplastic meningioma is a malignant type of meningioma with a high rate of recurrence and death. Given its rarity, minimal information regarding this tumour is available. Thus, we studied a series of patients with anaplastic meningiomas and analysed the survival rates, prognostic factors and treatment methods associated with these patients. Forty-three anaplastic meningioma cases treated at our hospital between July 2002 and June 2012 were compiled into a single database used to summarise the clinical characteristics from a retrospective review of patient records. Progression free survival (PFS) and overall survival (OS) were analysed as a function of each possible prognostic factor. The I, 3 and 5 year PFS rates were 90.7%, 513%, and 37.0%, respectively, whereas the corresponding values of OS rates were 95.3%, 68.0% and 49.2%, respectively. A number of factors were selected to analyse association with prognosis. Simpson Grade I and II resections exhibited increased PFS rates and radiotherapy improved the OS rate in anaplastic meningiomas. Tumours with homogeneous contrast enhancement on MRI were associated with increased PFS and OS. Sex, age, tumour location, first or transformed anaplastic tumour, pre-operative Karnofsky Performance Scores, tumour volumes and bone involvement had no significant effect on either PFS or OS. MRI homogeneous contrast may be a useful prognostic factor and surgery followed by radiotherapy is recommended for the treatment of anaplastic meningiomas. (C) 2015 Elsevier Ltd. All rights reserved.
机译:颅内间变性脑膜瘤是一种恶性类型的脑膜瘤,复发率和死亡率很高。鉴于其稀有性,关于该肿瘤的信息很少。因此,我们研究了一系列间变性脑膜瘤患者,并分析了这些患者的存活率,预后因素和治疗方法。 2002年7月至2012年6月在我院治疗的43例间变性脑膜瘤病例被汇总到一个数据库中,用于通过回顾性患者记录总结临床特征。根据每种可能的预后因素分析无进展生存期(PFS)和总生存期(OS)。 I,3和5年PFS率分别为90.7%,513%和37.0%,而OS率的相应值分别为95.3%,68.0%和49.2%。选择了许多因素来分析与预后的关系。辛普森I级和II级切除术显示间变性脑膜瘤的PFS率增加,放疗改善了OS率。 MRI上具有均一的对比增强作用的肿瘤与PFS和OS升高相关。性别,年龄,肿瘤位置,第一个或已转变的间变性肿瘤,术前卡诺夫斯基性能评分,肿瘤体积和骨骼受累对PFS或OS均无显着影响。 MRI均匀对比可能是有用的预后因素,建议手术后放疗以治疗间变性脑膜瘤。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号